Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

PVLAPVLA
3 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in Palvella Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 67,469 shares of PVLA (Palvella Therapeutics, Inc.), worth $10.3M as of 2026-Q2. The position was decreased (-3.5% shares). PVLA represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.

Current Value

$10.3M

Current Shares

67,469

Total Value Change

+$5.3M

Total Shares Change

+19,788

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
67,469
-3.5%
$10.3M0.0%$152.82
0
2026-Q1
Increased
69,901
+46.6%
$8.7M0.0%$131.51
38
2025-Q4
New
47,681
-
$5M0.0%$99.88
37

Other major holders of PVLA: JENNISON ASSOCIATES LLC, BlackRock, Inc., STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used